1 School of Population and Public Health, and.
2 Division of Respirology, University of Toronto, Toronto, Ontario, Canada.
Ann Am Thorac Soc. 2018 Oct;15(10):1177-1185. doi: 10.1513/AnnalsATS.201801-037OC.
Individuals diagnosed with cystic fibrosis (CF) as adults represent a growing subpopulation of CF cases, but there are limited studies describing their characteristics and prognosis.
The objectives of this study were to describe the clinical characteristics of individuals with adult-diagnosed CF, estimate survival rates in this population, and identify clinical predictors of reduced survival at baseline.
The Canadian CF Patient Registry was used to identify patients with CF who were ≥18 years of age at diagnosis and received a diagnosis between 1990 and 2014. Clinical characteristics were described and the Kaplan-Meier method was used to estimate lung-transplant-free survival. Multivariable Cox regression analysis and adjusted survival curves were employed to identify important predictors of reduced survival at the time of diagnosis (i.e., baseline) and to produce adjusted effects.
A total of 362 adults were diagnosed with CF during the study period. The median follow-up time was 7.7 years and 48 individuals experienced an event (15 transplants, 33 deaths without transplant). The median age at diagnosis was 34.3 years, with the majority of individuals presenting with pulmonary and/or gastrointestinal symptoms (71%). Lung-transplant-free survival was 88% at 10 years and 86% at 15 years. Age at diagnosis (hazard ratio [HR], 1.24 per 5-year increase, 95% confidence interval [CI], 1.09-1.43), diabetes (HR, 4.19; 95% CI, 1.35-13.01), and lung function (HR, 1.35 per 5% decrease in forced expiratory volume in 1 second % predicted; 95% CI, 1.24-1.48) at baseline were important predictors of reduced survival.
CF care providers can use this information to inform individuals who received a diagnosis of CF as adults about their prognosis and to guide the necessity of treatments, specifically with regard to those who are at high risk for a worse prognosis.
成年后被诊断为囊性纤维化(CF)的个体代表了 CF 病例的一个不断增长的亚群,但描述其特征和预后的研究有限。
本研究旨在描述成年后诊断为 CF 的个体的临床特征,估计该人群的生存率,并确定基线时降低生存率的临床预测因素。
使用加拿大 CF 患者登记处,确定在研究期间年龄≥18 岁且在 1990 年至 2014 年间被诊断为 CF 的患者。描述了临床特征,并使用 Kaplan-Meier 法估计肺移植无失败生存率。多变量 Cox 回归分析和调整后的生存曲线用于确定诊断时(即基线)降低生存率的重要预测因素,并产生调整后的效应。
在研究期间,共有 362 名成年人被诊断为 CF。中位随访时间为 7.7 年,有 48 人发生了事件(15 例移植,33 例无移植死亡)。诊断时的中位年龄为 34.3 岁,大多数患者表现出肺部和/或胃肠道症状(71%)。肺移植无失败生存率在 10 年时为 88%,在 15 年时为 86%。诊断时的年龄(风险比[HR],每增加 5 岁增加 1.24,95%置信区间[CI],1.09-1.43)、糖尿病(HR,4.19;95%CI,1.35-13.01)和基线时的肺功能(HR,每降低 5%预计用力呼气量 1 秒的百分比降低 1.35;95%CI,1.24-1.48)是降低生存率的重要预测因素。
CF 护理提供者可以使用这些信息告知成年后被诊断为 CF 的个体其预后,并指导治疗的必要性,特别是对于那些预后较差风险较高的患者。